The landscape of dementia diagnosis has evolved drastically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology years before indications arise. Although these technological developments represent extraordinary progress in knowing neurodegenerative illnesses, they have not diminishe... https://chapline197blu6.estate-blog.com/profile